多参数MRI包括T1ρ成像在脂肪性肝病临床前模型中评估肝纤维化
研究在57只脂肪性肝病大鼠模型中验证T1ρ成像对肝纤维化的诊断价值,并与常规T1、ECV、T2 mapping比较。T1ρ值在纤维化组升高,与纤维化标志物和门静脉压力相关,诊断纤维化的AUC达0.96,优于T1、ECV和T2。
要点
- T1ρ值在纤维化组升高,12周HFD+CCl₄组71±5毫秒 vs HFD组60±3毫秒,P<0.001。
- T1ρ诊断组织学纤维化的AUC为0.96,高于T1的0.74、ECV的0.79和T2的0.51。
- T1ρ与羟脯氨酸含量相关r=0.76,与门静脉压力相关r=0.55,均为P<0.001。
核心结论
- 在脂肪性肝病临床前模型中,T1ρ成像在多种mapping参数中最可靠地检出肝纤维化和门静脉高压。
研究设计与样本
- 动物实验,雄性Sprague-Dawley大鼠57只,分为12周HFD组n=15、6周HFD+CCl₄组n=14、12周HFD+CCl₄组n=16和对照组n=12,行定量MRI评估T1、ECV、T2和T1ρ,以组织学(天狼星红、α-SMA染色、羟脯氨酸含量)和侵入性门静脉压力测量为参考。
关键影像表现/征象
- T1ρ值在纤维化组升高,12周HFD+CCl₄组71毫秒±5 vs HFD组60毫秒±3,P<0.001。
诊断标准与关键数值
- T1ρ诊断组织学纤维化的AUC 0.96(P<0.001),T1的AUC 0.74(P=0.017),ECV的AUC 0.79(P=0.043),T2的AUC 0.51(P<0.001)。
- T1ρ是组织学纤维化检出的独立标志物,比值比3.81,P=0.02。
- T1ρ与纤维化标志物相关:天狼星红r=0.41,α-SMA r=0.67,羟脯氨酸r=0.76,各P<0.001;与门静脉压力r=0.55,P<0.001。
临床应用与阅片要点
- 在脂肪性肝病背景下,T1ρ成像可能较常规T1、ECV和T2 mapping更可靠地检出肝纤维化。
- T1ρ值与门静脉压力相关,可能有助于无创评估门静脉高压。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The diagnostic value of hepatic native T1, extracellular volume fraction (ECV), and T2 mapping for noninvasive assessment of liver fibrosis is limited in the complex spectrum of steatotic liver disease due to confounding factors, including hepatic fat and inflammation. Therefore, this study aimed to histologically validate T1ρ mapping and compare it with conventional mapping parameters for assessing hepatic fibrosis across different animal models of steatotic liver disease.
MATERIALS AND METHODS: In male Sprague-Dawley rats, different models of steatotic liver disease were induced using a high-fat diet (HFD) and carbon-tetrachloride (CCl 4 ) inhalation: (1) 12-week HFD group resulting in steatosis/steatohepatitis without fibrosis; (2) 6-week HFD + CCl 4 group resulting in steatohepatitis with fibrosis; (3) 12-week HFD + CCl 4 resulting in steatohepatitis-associated cirrhosis. Hepatic T1, ECV, T2, and T1ρ were assessed by quantitative MRI. Portal pressure was invasively measured. Hepatic fibrosis was assessed using Sirius red, alpha-smooth muscle actin (α-SMA) staining, and measurement of hydroxyproline content. Hepatic fat content was estimated in Oil red staining and triglyceride content.
RESULTS: Fifty-seven animals were analyzed (12-week HFD, n = 15; 6-week HFD + CCl 4 , n = 14; 12-week HFD + CCl 4 ; n = 16; controls, n = 12). T1ρ values were higher in the fibrosis groups, for example, 12-week HFD + CCl 4 versus HFD group (71 msec ±5 vs 60 msec ±3, P < 0.001). T1ρ values correlated with fibrosis markers (Sirius red r = 0.41; α-SMA: r = 0.67; hydroxyproline: r = 0.76; each P < 0.001) and portal pressure (r = 0.55, P < 0.001). T1ρ had the highest diagnostic performance for the detection of histologically defined fibrosis and invasively measured portal hypertension (eg, for fibrosis, T1ρ: AUC 0.96, P < 0.001; T1: AUC 0.74, P = 0.017; ECV: AUC 0.79, P = 0.043; T2: AUC 0.51, P < 0.001). T1ρ was an independent marker for the detection of histologically defined fibrosis (odds ratio: 3.81, P = 0.02).
CONCLUSIONS: In preclinical models of steatotic liver disease, T1ρ mapping could most reliably detect hepatic fibrosis and portal hypertension across different mapping parameters.
引用
- Mesropyan N, Schneider F, Lutz PC, et al. Multiparametric MRI Including T1ρ Mapping for Hepatic Fibrosis Assessment in Preclinical Models of Steatotic Liver Disease. Invest Radiol. 2025. PMID: 40208918. doi:10.1097/RLI.0000000000001193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。